Christopher Betz, Pharm.D., BCPS, FASHP, FKSHP
Professor, Department of Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Cardiology Clinical Pharmacy Specialist
Jewish Hospital Rudd Heart and Lung Center
Christopher Betz, Pharm.D., BCPS, FASHP, FKSHP, is Professor of the Department of Clinical and Administrative Sciences at the Sullivan University College of Pharmacy and a Cardiology Clinical Pharmacy Specialist with the Advanced Heart Failure Group at Jewish Hospital Rudd Heart and Lung Center in Louisville, KY. Dr. Betz is a residency trained, Board Certified Pharmacotherapy Specialist, and has been in clinical practice for approximately 17 years.
Dr. Betz is a member of the development team and a content matter expert for the ASHP Pharmacotherapy Review and Recertification Course where he has authored recertification programming and lectured on cardiology focused topics.
Dr. Betz has held faculty appointments and taught at three colleges of pharmacy on a multitude of internal medicine and cardiology topics, including the management of heart failure. He has also lectured to pharmacists, nurse practitioners, and physicians at local, regional, and national meetings. Dr. Betz has also served two years as the Cardiology Networking Facilitator for the ASHP Section of Clinical Specialists Scientists and continues to serve on the Scientific Committee for the Kentucky Chapter of the American College of Cardiology.
Snehal Bhatt, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Science
Beth Israel Deaconess Medical Center
Snehal Bhatt, Pharm.D., BCPS, is Associate Professor of Pharmacy Practice at the Massachusetts College of Pharmacy and Health Science in Boston where his primary focus is on cardiovascular topics. Dr. Bhatt’s clinical practice is in acute care cardiology at the Beth Israel Deaconess Medical Center where he manages the pharmacotherapy of patients with acute decompensated heart failure for the Acute Heart Failure and Left Ventricular Assist Device service---he has served in this role for approximately 11 years. In addition, Dr. Bhatt has also assisted in the development and implementation of institutional pharmacotherapeutic protocols and guidelines for heart failure patients.
Dr. Bhatt is a member of the development team and a content matter expert for the ASHP Pharmacotherapy Review and Recertification Course where he has authored recertification programming and lectured on cardiology focused topics, including acute decompensated heart failure. As a content matter expert within the pharmacotherapy course, he has developed, evaluated and reviewed literature study modules and intensive studies for recertification credits. Dr. Bhatt serves on the ASHP Council on Therapeutics, and is an active member of the American Heart Association and Heart Failure Society of America. In addition, he is an active member of the American College of Cardiology (ACC), serving on the Cardiovascular Team (CVT), Accreditation Compliance, and CVT Pharmacist Work Groups. Dr. Bhatt is currently the CVT Executive Committee Chair for the Massachusetts ACC
Meredith Keisler, Pharm.D., BCOP, CPP
Clinical Pharmacist Practitioner, Oncology Supportive Care Consult Service
University of North Carolina Healthcare
Hillsborough, North Carolina
Meredith D. Keisler, Pharm.D., BCOP, CPP, is Oncology Clinical Pharmacist Practitioner at the University of North Carolina (UNC) Medical Center. Dr. Keisler received her Doctor of Pharmacy degree from the UNC Eshelman School of Pharmacy and completed PGY1 pharmacy practice and PGY2 hematology/oncology residencies at the University of North Carolina Medical Center. Her research and practice interests focus on symptom management and medication adherence. Dr. Keisler was nominated for the 2016 Oncology Excellence Award at the UNC Comprehensive Cancer Center. She is currently a member of the multi-disciplinary Oncology Supportive Care team that provides palliative care for patients with cancer.
Patricia C. Kienle, R.Ph., M.P.A., FASHP
Director, Accreditation and Medication Safety
Cardinal Health Innovative Delivery Systems
Patricia C. Kienle, R.Ph., M.P.A., FASHP, is a well-recognized expert in medication safety, quality assurance, and regulatory affairs. Mrs. Kienle is a graduate of the University of the Sciences in Philadelphia and Marywood University in Scranton, Penn. She also completed an executive fellowship in patient safety at Virginia Commonwealth University and serves as adjunct associate professor at Wilkes University in Wilkes-Barre, Penn.
Mrs. Kienle has served on the Board of Directors of ASHP and as President of the Pennsylvania Society of Hospital Pharmacists. She has been a member of the United States Pharmacopeia Compounding Expert Committee since 2010, serving as Vice-Chair, and as Chair, Subcommittee on Hazardous Drugs. Mrs. Kienle is author of Compounding Sterile Preparations: ASHP's Video Guide to Chapter <797> Workbook, co-author of Assuring Continuous Compliance with Joint Commission Standards: A Pharmacy Guide, and author of the upcoming ASHP publication, The 800 Answer Book. She is a frequent presenter at pharmacy, nursing, and medical educational meetings.
Joel Marrs, Pharm.D., BCACP, BCPS-AQ Cardiology, FASHP, FCCP, FNLA
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Clinical Pharmacy Specialist
Denver Health Medical Center
Joel Marrs, Pharm.D., BCACP, BCPS-AQ Cardiology, FASHP, FCCP, FNLA, is Associate Professor at the University of Colorado School of Pharmacy in Aurora and a clinical pharmacy specialist focusing on cardiovascular and metabolic pharmacotherapy with the Denver Health Medical Center (DHMC). As a faculty member of the University of Colorado School of Pharmacy, Dr. Marrs precepts pharmacy students on Advanced Pharmacy Practice Experiential rotations, PGY1 residents (DHMC) and PGY2 ambulatory care residents. He also directs the teaching and learning certificate program and speaks on the topic of giving and utilizing effective feedback in the pharmacy workplace.
Dr. Marrs earned his Doctor of Pharmacy degree from Butler University and completed two years of residency—the first at Mount Carmel Medical Center in Columbus, Ohio, and the second specializing in family medicine at the University of Colorado in Denver. Dr. Marrs is a Board Certified Pharmacotherapy Specialist with added qualifications in cardiology and a Board Certified Ambulatory Care pharmacist. He is a fellow of the ASHP, American College of Clinical Pharmacy, and National Lipid Association. He has served on ASHP’s Council on Therapeutics and the Section of Clinical Specialists and Scientists’ Educational Steering Committee and has presented on a number of cardiovascular and educational topics at the ASHP Summer and Midyear Clinical Meetings. Dr. Marrs serves as faculty for the ASHP Board Certification Review Courses for Pharmacotherapy and Ambulatory Care. He has directed two teaching certificate programs (Oregon 2007-2009 and Colorado 2010-present) focused on preparing residents and fellows on the key aspects of academia.
Krystal Moorman, Pharm.D., BCPS
Director Experiential Education and Assistant Clinical Professor
University of Utah College of Pharmacy
Salt Lake City, Utah
Krystal Moorman, Pharm.D., BCPS, is Director of Experiential Education and Clinical Assistant Professor at the University of Utah College of Pharmacy in Salt Lake City. Dr. Moorman earned a Doctor of Pharmacy degree from the Medical University of South Carolina College of Pharmacy in Charleston and completed PGY1 Pharmacy Practice and PGY2 Drug Information residencies at the Medical University of South Carolina. Prior to joining the faculty at the University of Utah College of Pharmacy, she served as the Coordinator of Drug Information and Medication Safety at Intermountain Medical Center in Murray, Utah, and was a Drug Information Specialist at Kaiser Permanente in Denver, Colorado.
Dr. Moorman’s interests include drug information and medication safety. She is an active member of the Utah Society of Health-System Pharmacists---serving as President and now Immediate Past President. Dr. Moorman has served as Chair and member, ASHP Program Committee; Delegate, 2015 ASHP House of Delegates; and Alternate Delegate, 2016 ASHP House of Delegates. Dr. Moorman has served on the ASHP Advisory Group for Preceptor Development and on the Council on Education and Workforce Development.
Marc H. Scheetz, Pharm.D., M.S., BCPS-AQ ID
Associate Professor Midwestern University
Downers Grove, Illinois
Infectious Diseases Pharmacist
Northwestern Memorial Hospital
Marc H. Scheetz, Pharm.D., M.S., BCPS-AQ ID, is Associate Professor and Infectious Disease Pharmacist at Midwestern University Chicago College of Pharmacy in Downers Grove, Illinois, where he teaches clinical pharmacokinetics and conducts translational pharmacometric research. Dr. Sheetz is Infectious Diseases Pharmacist at Northwestern Memorial Hospital in Chicago, Illinois, and serves as the Director for the Infectious Diseases Pharmacotherapy Fellowship. Dr. Sheetz received a Doctorate of Pharmacy from Butler University in Indianapolis, Indiana; earned a Masters of Science in Clinical Investigation degree at Northwestern University in Evanston, Illinois; completed a PGY1 Pharmacy Practice Residency and Infectious Diseases Fellowship at Northwestern Memorial Hospital in Chicago, Illinois.
Dr. Scheetz’s primary research interest is the pharmacokinetic/pharmacodynamic interaction between antimicrobials, pathogens, and hosts. He is particularly interested in assessing modifiable pharmacologic variables in the treatment of infectious diseases and designing safer dosing strategies. Dr. Scheetz’s research is funded by the National Institutes of Health, state grants, and various other organizations. He has authored over 90 original research manuscripts and review articles in the area of antiinfective pharmacokinetics and pharmacodynamics. Dr. Scheetz is actively engaged in local and national leadership positions and is a standing member of the FDA Anti-Infective Drugs Advisory Committee and Associate Editor, Journal of Infection and Chemotherapy.
Douglas Slain, Pharm.D., B.S.Pharm., BCPS, FASHP
Professor and Infectious Diseases Clinical Specialist
West Virginia University (WVU) and WVU Hospitals and Clinics
Douglas Slain, Pharm.D., B.S.Pharm., BCPS, FASHP, is Professor and Infectious Diseases Clinical Specialist at West Virginia University and WVU Hospitals and Clinics. Dr. Slain received his Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees from Duquesne University. He completed a residency and fellowship in Infectious Diseases Pharmacotherapy at Virginia Commonwealth University & The Medical College of Virginia Hospitals in Richmond. Dr. Slain’s clinical practice sites at WVU include the Infectious Diseases Consult Service and the Outpatient Infectious Diseases Clinic.
Dr. Slain served as West Virginia Society of Health-System Pharmacists Vice President (2011-2013). He has served on the ASHP’s Section of Clinical Specialists and Scientists Educational Steering Committee; Chair, ASHP Council on Therapeutics; voting member, Pharmacy Practice Model Initiative Summit; ASHP Task Force on Organizational Structure; Director-At-Large, ASHP Section of Clinical Specialists and Scientists Executive Committee; and served on the Society of Infectious Diseases Pharmacists Board of Directors (2012-2014). Dr. Slain is a Board Certified Pharmacotherapy Specialist and is a Fellow of ASHP.
Kyana D. Stewart, Pharm.D., M.S., BCPS
Infectious Diseases Clinical Pharmacy Specialist
Adult & Pediatric Infectious Diseases
Ochsner Medical Center
New Orleans, LA
Dr. Stewart joined the Ochsner Clinical Pharmacy team in 2018 as an Infectious Diseases Clinical Specialist Pharmacist. In her current role she works collaboratively with other ID Clinical Specialists to provide infectious diseases pharmacotherapy support to the Ochsner Infectious Diseases consult services as well as contributing to the growth and expansion of the antimicrobial stewardship program at Ochsner Medical Center. She earned her B.S. in Chemistry from Southern University and A&M College (Baton Rouge, LA), her M.S. in Environmental Engineering from University of Florida (Gainesville, FL), and her Doctor of Pharmacy from the University of Houston College of Pharmacy (Houston, TX). Following completion of her PharmD she completed residency training at Huntsville Hospital System (Huntsville, AL). Prior to joining the team at Ochsner she has served in multiple roles including Antimicrobial Stewardship Program Co - Chair (Children’s Medical Center - Dallas), Clinical Instructor, Pediatrics (UTSW Medical School), Assistant Professor of Pharmacy Practice (Texas Tech University Health Sciences Center) all leading to the development & implementation of antimicrobial stewardship programs and provision of didactic and experiential learning experiences for pharmacy students & residents, medical residents & fellows respectively.
Her primary research and clinical interests are optimization of pharmacodynamic and pharmacokinetic parameters of antimicrobial agents in special populations, antimicrobial impacts on the gut microbiome, and mechanisms of antimicrobial resistance.
Amie Taggart Blaszczyk, Pharm.D., BCGP, BCPS, FASCP
Associate Professor and Division Head - Geriatrics
Texas Tech University Health Sciences Center School of Pharmacy-Dallas/Fort Worth
Amie Taggart Blaszczyk, Pharm.D., BCGP, BCPS, FASCP, is Associate Professor of Geriatric Pharmacy Practice and the Division Head of Geriatrics at the Texas Tech University Health Sciences Center School of Pharmacy on the Dallas/Fort Worth campus with an affiliated practice with Senior Care Centers. She earned her Doctor of Pharmacy from Duquesne University and completed a pharmacy practice residency in Milwaukee, Wisconsin, and a specialty residency in geriatric pharmacotherapy in Baltimore, Maryland. Dr. Taggart Blaszczyk focuses on the population level interventions which can positively affect the quality of care of long-term care residents. She also serves as the residency director for the ASHP-accredited PGY2 Geriatric Pharmacotherapy residency program.
Dr. Taggart Blaszczyk’s practice and research interests include neurodegenerative diseases affecting older individuals, senior education, and the impact of a clinical pharmacist working in the long-term care setting. She is a member of the American Society of Consultant Pharmacists (ASCP), is the President of the Texas chapter of ASCP, and serves on the editorial board of The Consultant Pharmacist. She is also an active member of the American College of Clinical Pharmacy and American Society of Health-System Pharmacists. Dr. Taggart Blaszczyk is a Board Certified Geriatric Pharmacist, Board Certified Pharmacotherapy Specialist, and a Fellow of the ASHP.